Navigation Links
Stereotaxis Reports 2010 Financial Results, Provides 2011 Financial Outlook
Date:2/28/2011

ash burn for the fourth quarter of 2010 was $5.6 million.

The operating loss for the fourth quarter 2010 was $(3.4) million, compared to an operating loss of $(5.8) million for the fourth quarter 2009.  The net loss for the fourth quarter 2010 was $(2.5) million, or $(0.05) per share, compared to a net loss of $(6.7) million, or $(0.14) per share, reported for the fourth quarter 2009.  Net loss for the fourth quarter 2010 included other income of $1.5 million in federal grants under the Qualifying Therapeutic Discovery Project Program that was enacted under the Patient Protection and Affordable Care Act of 2010.  The weighted average shares for the fourth quarter of 2010 totaled 52.5 million compared with 48.4 million in the fourth quarter of last year.  The increase was due in large part to the issuance of 4.6 million shares as part of the stock offering completed in November 2010.

At December 31, 2010, Stereotaxis had cash and cash equivalents of $35.2 million, compared to $21.8 million on September 30, 2010.  Total debt was $28.9 million, including $11.0 million drawn against the Company's $30 million line of credit.

2011 Financial OutlookStereotaxis provided its outlook for 2011 as follows:

  • New capital order growth expected to be in the mid-30% range
  • Total revenue growth expected to be in the range of 20% to 30%
  • Gross margins expected to be in the high-60% range
  • Operating expenses expected to be in the range of $62 million to $63 million

  • Conference Call InformationStereotaxis will hold a conference call today, February 28, 2011 at 4:30 p.m. Eastern Time, to discuss fourth quarter and full year 2010 results and operational highlights.  The dial-in number for the conference call is 1-877-941-6010 for domestic participants and 1-480-629-9772 for international participants.  An audio replay of the call will be available for seven days following the
    '/>"/>

    SOURCE Stereotaxis, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7

    Related medicine technology :

    1. Stereotaxis Market Leadership Reinforced in Core Curriculum and Symposium Presentations at Heart Rhythm 2008
    2. Stereotaxis Receives Commitment to Increase and Extend Its Credit Facility With Silicon Valley Bank
    3. Stereotaxis Announces Public Offering of Common Stock
    4. Stereotaxis Announces Pricing of $26 Million Common Stock Offering
    5. Stereotaxis Announces Underwriters Exercise of Over-Allotment Option
    6. Stereotaxis Receives Notice of European Approval of an Additional Magnetic Irrigated Catheter
    7. Stereotaxis System Procedure Featured on NBCs The TODAY Show
    8. Stereotaxis is Notified of the FDA Approval of an Additional Magnetic Irrigated Catheter
    9. Stereotaxis Installs First System in Taiwan
    10. Stereotaxis Updates Progress on Major Clinical Initiative Related to Electrophysiology (EP) Treatment of Ventricular Tachycardia
    11. Stereotaxis Announces Vdrive(TM), a New Technology for Remote Navigation of Diagnostic Devices
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/3/2015)... , Sept. 3,  2015 About ... bio-artificial devices, which are implanted or integrated ... organs. These include artificial heart, kidney, pancreas, ... polymers (polyurethane, polysulfone, and porous polypropylene), biologics, ... artificial organs. These organs are incorporated with ...
    (Date:9/3/2015)... 3, 2015 About dry eye syndrome Dry ... to deficient tear production or quick tear evaporation or ... types: aqueous tear deficient dry eye and evaporative dry ... do not produce enough tears, whereas meibomian gland dysfunction ... to slow tear evaporation and maintain tear stability. The ...
    (Date:9/3/2015)... Sept. 3, 2015  Ascendis Pharma A/S ... biotechnology company that applies its innovative TransCon ... today announced plans to present at several ... Healthcare Conference in BostonDate: , Thursday, September ... of America Merrill Lynch Global Healthcare Conference ...
    Breaking Medicine Technology:Global Artificial Organ Market 2015-2019 2Global Dry Eye Syndrome Market 2015-2019 2Ascendis Pharma A/S to Present at Three Upcoming Investor Conferences 2
    ... WIRE)--May 21, 2007 - Cougar Biotechnology,Inc. (OTCBB:CGRB) today ... on the Company's prostate cancer drug candidate CB7630,(abiraterone ... Annual Meeting, which is currently taking place,in Anaheim, ... A.,Yap from the Cancer Research UK Centre for ...
    ... 40/12.5 and 40/25 mg/day and Amlodipine +,Benazepril ... Society of,Hypertension Twenty-Second Annual Scientific Meeting, PARSIPPANY, ... data,presented today at the American Society of ... Chicago,demonstrated that the fixed-dose combination Benicar HCT,(olmesartan ...
    Cached Medicine Technology:Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 2Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 3Cougar Biotechnology Announces Presentation of Positive CB7630,Clinical Data at AUA Annual Meeting 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 2Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 3Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 4Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 5Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 6Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 7Benicar HCT Reductions in Seated Systolic Blood Pressure for Stage,2 Patients Compared With Amlodipine + Benazepril 8
    (Date:9/4/2015)... ... 2015 , ... Inmar announced today that its regulatory experts ... Quality and Manufacturers, Dietary Supplements and Supply Chain Committees. , With the complex ... industry, it can be difficult for companies to navigate, stay abreast of all ...
    (Date:9/4/2015)... ... September 04, 2015 , ... ... technology is now available at CitiDent. CEREC is a newer method for creating ... saving time for patients by eliminating the need for multiple appointments, CEREC produces ...
    (Date:9/4/2015)... ... 04, 2015 , ... Bio-Logic Aqua® Research, a fresh water ... only mission and research focus: Water Life Science®. In the current warming and ... is becoming dangerously accelerated. As a result of the global fresh water, water ...
    (Date:9/4/2015)... ... September 04, 2015 , ... ... of its first neighborhood created specifically for adults with intellectual, developmental and acquired ... Metro area and feature 30 cottage or “pocket” homes. In this community, adults ...
    (Date:9/4/2015)... ... 04, 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, has written ... the Pope’s upcoming trip to the United States. , Yisrayl lays out what he says ... Vatican and society is. Yisrayl also provides the meaning of his own name and describes ...
    Breaking Medicine News(10 mins):Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 2Health News:Inmar Experts To Address OTC Manufacturers’ Session on Hazardous Waste and Handling at CHPA Meeting 3Health News:San Francisco Dentist, Dr. Ben Amini, is Now Offering CEREC Technology at CitiDent 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 2Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 3Health News:Cottage Home Communities for Disabled Adults to Create First Viable Permanent Housing Option 4Health News:Yisrayl Hawkins Writes Open Letter to Pope Francis In Light of Approaching U.S. Visit 2
    ... other form of treatment. But to a benefit of all GPs ... ,A resident artist much like resident doctors has been ... Susan Grant, a graduate of the Edinburgh School of Art. ... Council. ,It is one of 27 projects across Scotland ...
    ... Abdul Kalam today met representatives of the striking medicos ... the students and doctors deciding// to continue with their ... also included members of AIIMS Faculty Association who have ... with Kalam. The medicos presented a charter of demands ...
    ... India's northeast has led to a rise in drug abuse ... United Nations study. ,"Drug trafficking across the common border ... Nagaland occurs with ease. Despite the existence of heavy security, ... the local youths of these states," said a report released ...
    ... couple has revealed how a mistake at an IVF clinic almost ... spoke of the emotional trauma// that they had to undergo when ... with an Asian man's sperm. ,The couple had twins ... treated at a fertility clinic run by Leeds NHS Trust. "I ...
    ... can be attributed to genes, says a new finding ... ,Researchers led by Richard P. Ebstein, a professor of ... DNA of 148 healthy male and female Israeli university ... compared the results, they found that common variations in ...
    ... centres in Singapore and India plan to expand joint ... cancer centre said Tuesday//. ,The cooperation between Singapore's ... Centre builds on a screening programme credited with cutting ... the Indian state by 40 percent. ,The ...
    Cached Medicine News:Health News:President Kalam Meets Striking Medicos However Stir to Continue 2Health News:Illegal Drug Trafficking Pose A Great Threat For HIV Epidemic In Northeast 2
    Enzyme Immunoassay for the Quantitative Measurement of Ovarian Cancer Antigen CA-125 in Human Serum...
    Test for prostatic acid phosphatase...
    The MOSAIC PET scanner is designed to meet the exacting requirements of animal research imaging. Supported by proven Philips technology, MOSAIC provides a leading edge PET solution for reliable in-vi...
    ... iMRI is a neurosurgical OR that ... diagnostic tools, including iMRI, necessary to ... iMRI, neurosurgical treatments are performed in ... designed for MR compatibility and safety, ...
    Medicine Products: